2021
DOI: 10.21037/atm-21-4323
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of reporting quality in clinical practice guidelines for acute myeloid leukemia using the RIGHT checklist

Abstract: Background: Acute myeloid leukemia (AML) is an aggressive hematologic malignancy. Clinical practice guidelines (CPGs) on the management of AML have great value in clinical practice. However, the reporting quality of CPGs for AML has not yet been evaluated. This is the first study aiming to evaluate the reporting quality of the most recent AML CPGs published worldwide using the Reporting Items for Practice Guidelines in Healthcare (RIGHT) checklist.Methods: We systematically searched PubMed, Chinese National Kn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…Therefore, in 2017, the international RIGHT (Reporting Items for Practice Guidelines in Healthcare) Working Group produced a checklist to help guideline developers report CPGs, support peer reviewers and editors of journals when considering the guideline reports, and assist healthcare professionals comprehend and implement guidelines (10). The RIGHT checklist has been applied to evaluate the reporting quality of CPGs on many diseases (11)(12)(13)(14)(15). There is no evaluation study on the reporting quality of the CPGs in BLCA.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, in 2017, the international RIGHT (Reporting Items for Practice Guidelines in Healthcare) Working Group produced a checklist to help guideline developers report CPGs, support peer reviewers and editors of journals when considering the guideline reports, and assist healthcare professionals comprehend and implement guidelines (10). The RIGHT checklist has been applied to evaluate the reporting quality of CPGs on many diseases (11)(12)(13)(14)(15). There is no evaluation study on the reporting quality of the CPGs in BLCA.…”
Section: Introductionmentioning
confidence: 99%